ArticleClinical journal of gastroenterology2020
Real-word efficacy of sofosbuvir, velpatasvir plus ribavirin therapy for chronic hepatitis patients who failed to prior DAA therapy with NS5A-P32 deletion mutated HCV infection.
Shintaro Takaki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it